Product description
Drug product for the treatment of infective diarrhea (adult and children), traveler's diarrhea and dysbiosis. Based on proprietary probiotic strain SF68®, with unique characteristics and manufactured under pharmaceuticals GMPs. Its efficacy is supported by more than 20 clinical trials and its safety is confirmed by a recent (2018) publication and by more than 100 million patients treated along 40 years of commercialization.
Registered as drug product in Switzerland (Bioflorin), Austria, Italy and Korea.
Available a full CTD dossier and a CPP (Certificate of Pharmaceutical Product) from Switzerland.
Cerbios is looking for commercial Partners worldwide.
Read more